158798-73-3

  • Product Name:Capecitabine
  • Molecular Formula:C15H22FN3O6
  • Purity:99%
  • Molecular Weight:359.355
Inquiry

Product Details;

CasNo: 158798-73-3

Molecular Formula: C15H22FN3O6

Reliable Quality Reputable Manufacturer Supply Capecitabine 158798-73-3 with Efficient Delivery

  • Molecular Formula:C15H22FN3O6
  • Molecular Weight:359.355
  • Vapor Pressure:0mmHg at 25°C 
  • Refractive Index:1.7 
  • Boiling Point:437.874°C at 760 mmHg 
  • Flash Point:218.619°C 
  • PSA:122.91000 
  • Density:1.49 g/cm3 
  • LogP:0.83320 

Capecitabine(Cas 158798-73-3) Usage

Originator

Xeloda,Hoffmann - La Roche Inc.,USA

Therapeutic Function

Antitumor

InChI:InChI=1/C9H12FN3O4/c1-3-5(14)6(15)8(17-3)13-2-4(10)7(11)12-9(13)16/h2-3,5-6,8,14-15H,1H3,(H2,11,12,16)/t3-,5-,6-,8-/m1/s1

158798-73-3 Relevant articles

Preparation of capecitabine intermediate

-

Paragraph 0025-0028, (2021/09/01)

The invention belongs to the field of me...

Capecitabine intermediate

-

Paragraph 0043; 0107; 0110-0111, (2020/07/24)

The invention belongs to the field of me...

Cytidine derivative and method for preparing capecitabine medicines through derivative

-

Paragraph 0065-0069, (2020/05/14)

The invention discloses a 5-deoxy-D-ribo...

Continuous-Flow Sequential Schotten-Baumann Carbamoylation and Acetate Hydrolysis in the Synthesis of Capecitabine

Miranda, Leandro S. De M.,De Souza, Rodrigo O. M. A.,Lea?, Raquel A. C.,Carneiro, Paula F.,Pedraza, Sergio F.,De Carvalho, Otavio V.,De Souza, Stefania P.,Neves, Rebeca V.

, p. 2516 - 2520 (2019/11/03)

Capecitabine is an important anticancer ...

158798-73-3 Process route

pentyl chloroformate
638-41-5

pentyl chloroformate

(2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-5-methyl-tetrahydrofuran-3,4-diyl diacetate
161599-46-8,2230479-30-6

(2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-5-methyl-tetrahydrofuran-3,4-diyl diacetate

capecitabine
154361-50-9,158798-73-3

capecitabine

Conditions
Conditions Yield
With sodium hydroxide; In water; acetone; at 30 ℃; for 5h; Green chemistry;
82%
pentyl chloroformate; (2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-5-methyl-tetrahydrofuran-3,4-diyl diacetate; With pyridine; In dichloromethane; at 0 ℃; for 1h;
With sodium hydroxide; In ethanol; water; at -5 - 0 ℃; for 0.233333h;
80.2%
Multi-step reaction with 2 steps
1: dichloromethane
2: sodium hydroxide / methanol
With sodium hydroxide; In methanol; dichloromethane;
Multi-step reaction with 2 steps
1: pyridine / dichloromethane / 1 h / 0 °C
2: sodium methylate / methanol / 1 h / 20 °C
With pyridine; sodium methylate; In methanol; dichloromethane;
Multi-step reaction with 2 steps
1: potassium phosphate / isopropyl alcohol; dichloromethane / 4 h / 0 - 25 °C / Inert atmosphere
2: sodium hydroxide / methanol; water / 1 h / -10 - 5 °C / Autoclave
With potassium phosphate; sodium hydroxide; In methanol; dichloromethane; water; isopropyl alcohol;
2'3'-O-isopropylidene-5'-deoxy-5-fluoro-N<sub>4</sub>-(pentyloxycarbonyl)cytidine

2'3'-O-isopropylidene-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine

capecitabine
154361-50-9,158798-73-3

capecitabine

Conditions
Conditions Yield
With trifluoroacetic acid; In methanol; dichloromethane; water; at 10 - 20 ℃; for 3h; Solvent;
89.4%

158798-73-3 Upstream products

  • 162204-20-8
    162204-20-8

    N1-(2',3'-di-O-acetyl-5'-deoxy-β-D-ribofuranosyl)-5-fluoro-N4-(pentyloxycarbonyl)cytosine

  • 638-41-5
    638-41-5

    pentyl chloroformate

  • 161599-46-8
    161599-46-8

    (2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-5-methyl-tetrahydrofuran-3,4-diyl diacetate

  • 27821-07-4
    27821-07-4

    1,2,3-tri-O-acetyl-5-deoxy-β-D-ribofuranose

158798-73-3 Downstream products

  • 66335-38-4
    66335-38-4

    5'-deoxy-5-fluorocytidine

Relevant Products